Late-occurring toxicity induced by an immune checkpoint blockade in adjuvant treatment of a stage III melanoma patient

被引：24
|
作者：
Mandala, Mario [1 ]
Merelli, Barbara [1 ]
Indriolo, Amedeo [2 ]
Tondini, Carlo [1 ]
机构：
[1] Papa Giovanni XXIII Hosp, Dept Hematol & Oncol, Med Oncol Unit, Bergamo, Italy
[2] Papa Giovanni XXIII Hosp, Gastroenterol Unit, Bergamo, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 95卷
关键词：
ANTI-PD-1; THERAPY; IPILIMUMAB;
D O I：
10.1016/j.ejca.2018.02.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：130 / 132
页数：3
相关论文
共 50 条
  • [31] Adjuvant treatment for stage III melanoma in the era of targeted medicine and immunotherapy
    Ben-Ami, Eytan
    Schachter, Jacob
    MELANOMA MANAGEMENT, 2016, 3 (02) : 137 - 147
  • [32] Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade
    Mengoni, Miriam
    Braun, Andreas Dominik
    Hinnerichs, Mattes Simon
    Aghayev, Anar
    Tueting, Thomas
    Surov, Alexey
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (05)
  • [33] The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma
    Del Castillo, Maria
    Romero, Fabian A.
    Arguello, Esther
    Kyi, Chrisann
    Postow, Michael A.
    Redelman-Sidi, Gil
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (11) : 1490 - 1493
  • [34] BEYOND IMMUNE CHECKPOINT BLOCKADE: MANIPULATION OF T CELL REGULATORY CIRCUITS IN THE TREATMENT OF MELANOMA
    Sharma, P.
    Allison, J.
    INFLAMMATION RESEARCH, 2011, 60 : 25 - 26
  • [35] Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma
    Li, Si Ni
    Wan, Xiaomin
    Peng, Liu Bao
    Li, Ya Min
    Li, Jian He
    BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [36] Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma
    Si Ni Li
    Xiaomin Wan
    Liu Bao Peng
    Ya Min Li
    Jian He Li
    BMC Health Services Research, 23
  • [37] Successful Treatment of an Immune-Mediated Colitis Induced by Checkpoint Inhibitor Therapy in a Patient with Advanced Melanoma
    Paparoupa, Maria
    Stupperich, Sophie
    Goerg-Reifenberg, Lisa
    Wittig, Andreas
    Schuppert, Frank
    CASE REPORTS IN GASTROENTEROLOGY, 2020, 14 (03) : 554 - 560
  • [38] Patient Preferences and Satisfaction with Treatment Decisions in Stage III Melanoma
    Bredbeck, B.
    Mott, N.
    Dossett, L.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S108 - S108
  • [39] Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: a case series
    Bowden, Acacia
    Zambito, Jeanette
    El-Feghaly, Jinia
    Andolina, Jeffrey R.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2024, 41 (06) : 389 - 398
  • [40] Correction to: New paradigm for stage III melanoma: from surgery to adjuvant treatment
    Paolo Antonio Ascierto
    Lorenzo Borgognoni
    Gerardo Botti
    Michele Guida
    Paolo Marchetti
    Simone Mocellin
    Paolo Muto
    Giuseppe Palmieri
    Roberto Patuzzo
    Pietro Quaglino
    Ignazio Stanganelli
    Corrado Caracò
    Journal of Translational Medicine, 17
12345